Skip to content
Open access

Type I interferon activation in classical monocytes and GZMK+ CD8+ T cells characterises the ultrasound-negative phase of imminent rheumatoid arthritis.

Oct 2026 · Annals of the Rheumatic Diseases · 0 citations · 46 references
Medicine

TL;DR

In ACPA+ high-risk individuals, IFN-I-driven activation of peripheral innate CD14+ classical monocytes and GZMK+ CD8+ T cell subsets occur before the onset of subclinical synovitis when RA is imminent.

Abstract

Objectives

Rheumatoid arthritis (RA) is a prototypical autoimmune disease, characterised by prolonged systemic autoimmunity before organ-specific tissue inflammation. Understanding immune mechanisms that drive the transition from systemic autoimmunity to joint-specific pathology is key to arthritis prevention. In this study, we define immune signatures in anticitrullinated protein antibodies-positive (ACPA+) at-risk individuals who imminently progress to RA, comparing those with and without ultrasound (US)-detectable subclinical synovitis.

Methods

We performed single‑cell RNA sequencing and proteomic profiling on prospectively collected blood samples from high-risk ACPA+ imminent progressors (n = 22), who were further stratified by the presence or absence of US-detectable subclinical synovitis and compared them with ACPA+ nonprogressors (n=18).

Results

We found type I interferon (IFN-I) upregulation in peripheral CD14+ classical monocyte and Granzyme K protein (GZMK)+ CD8+ T cells in US-negative (USneg, n = 11) imminent progressors. In contrast, US-positive (USpos, n = 11) progressors exhibited a phenotypic shift in CD14+ classical monocytes towards interleukin 1 beta (IL1ß)+ expression and clonal expansion of GZMB+ cytotoxic CD8+ T cells. GZMB+ and GZMK+ CD8+ T cells were largely clonotypically distinct. Plasma proteomics also revealed a shift from Toll-like receptor-associated innate pathways in USneg progressors towards effector and tissue-remodelling signatures in USpos progressors.

Conclusions

In ACPA+ high-risk individuals, IFN-I-driven activation of peripheral innate CD14+ classical monocytes and GZMK+ CD8+ T cell subsets occur before the onset of subclinical synovitis when RA is imminent. Distinct inflammatory and effector programmes, including GZMB+ CD8+ T cells clonal expansion, are associated with the onset of subclinical synovitis.

Read PDF

Similar papers

Open access Oct 2026

IL-15 drives antigen-independent increase in granzyme K+B+ CD8 T cells enriched in rheumatoid arthritis joints.

OBJECTIVES CD8 T cells co-expressing granzymes K and B (GzmK + B+) are enriched in the joint compared with peripheral blood and have been implicated in the pathogenesis of rheumatoid arthritis (RA). However, it remains unclear whether the enrichment of GzmK+B+ subsets is specific to RA. In addition, the mechanism under...

Takahiro Natori, Hisakata Yamada, Ryosuke Tsurui et al. · 0 citations
Open access Nov 2026

Granzyme K associates with inflammatory immune programs and B-cell dysregulation in systemic lupus erythematosus

Findings identify circulating GZMK as an independent correlate of SLE clinical activity and characterize a recurrent GZMK-enriched CD8 + memory/Tem cell program across peripheral blood and affected tissues that is associated with B-cell dysregulation and plasma-cell-related immune abnormalities.

Yun-Jing Pu, Zhong-Yu Chen, Pei-Hui Yang et al. · 0 citations
Open access Nov 2026

Interleukin-12 Is Associated with Rheumatoid Factor and Interferon-γ, but Not with Disease Activity, in Patients with Rheumatoid Arthritis

It is found that serum IL-12 levels were associated with interferon-γ levels and rheumatoid factor positivity in patients with RA, supporting a role for IL-12 at the interface between cellular and humoral immunity.

I. Ferraz-Amaro, J. C. Quevedo-Abeledo, Enrique García-Barrera et al. · 0 citations
Oct 2026

Single-cell analysis reveals CXCL16+ dendritic cells and clonally expanded GZMK+ CD4 T cells driving joint inflammation in psoriatic arthritis.

OBJECTIVE Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis affecting approximately 30% of individuals with psoriasis. The mechanisms driving PsA joint inflammation remain incompletely defined. METHODS To address this gap, we performed multimodal single-cell sequencing of immune cells from matched peri...

Briana J. Mullins, Jasmine J. Shwetar, Alberto Herrera et al. · 0 citations
Open access Oct 2026

IFN-γ, TNF-α, IL-10, IL-17 and IL-22 secretion capacities and activation profile of T cells in psoriatic arthritis patients under disease-modifying antirheumatic drug therapy

Introduction While biologic disease-modifying antirheumatic drugs (bDMARDs) have transformed management, achieving complete remission remains a challenge due to complex immune networks in Psoriatic arthritis (PsA). This study aimed to characterize the functional modulation of circulating T-helper (Th) and cytotoxic T (...

Sibel Goksen, G. Ayan, U. Kalyoncu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.